APA aipamena

Getachew, Y., Cusimano, F. A., Gopal, P., Reisman, S. A., & Shay, J. W. (2016). The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury. Toxicol Sci.

Chicago Style aipamena

Getachew, Yonas, Frank A. Cusimano, Purva Gopal, Scott A. Reisman, and Jerry W. Shay. "The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury." Toxicol Sci 2016.

MLA aipamena

Getachew, Yonas, et al. "The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury." Toxicol Sci 2016.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.